These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20547443)

  • 21. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
    Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A feasibility study on adaptive
    Schatteman J; Van Gestel D; Berwouts D; De Gersem W; De Kerf G; De Neve W; De Ost B; Olteanu AML; Rottey S; Vercauteren T; Goethals I; Duprez F
    Strahlenther Onkol; 2018 Aug; 194(8):727-736. PubMed ID: 29556677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
    Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
    Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
    Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
    Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
    Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
    Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.
    Kharofa J; Choong N; Wang D; Firat S; Schultz C; Sadasiwan C; Wong S
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):690-5. PubMed ID: 22112556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
    Heron DE; Ferris RL; Karamouzis M; Andrade RS; Deeb EL; Burton S; Gooding WE; Branstetter BF; Mountz JM; Johnson JT; Argiris A; Grandis JR; Lai SY
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1493-500. PubMed ID: 19464819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.
    Cannon DM; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):660-5. PubMed ID: 18037580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
    Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.
    Ward MC; Riaz N; Caudell JJ; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Vargo JA; Heron DE; Higgins KA; Beitler JJ; Marcrom S; Boggs DH; Hassanzadeh C; Reddy CA; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA;
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):586-594. PubMed ID: 28865925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
    Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
    Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration.
    Lee C; Langen KM; Lu W; Haimerl J; Schnarr E; Ruchala KJ; Olivera GH; Meeks SL; Kupelian PA; Shellenberger TD; Mañon RR
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1563-71. PubMed ID: 18538505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancer.
    Chen AM; Cao M; Hsu S; Lamb J; Mikaeilian A; Yang Y; Agazaryan N; Low DA; Steinberg ML
    Adv Radiat Oncol; 2017; 2(2):167-175. PubMed ID: 28740928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily kV cone-beam CT and deformable image registration as a method for studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer.
    Elstrøm UV; Wysocka BA; Muren LP; Petersen JB; Grau C
    Acta Oncol; 2010 Oct; 49(7):1101-8. PubMed ID: 20831502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.